SCHEMBL7657357

SCHEMBL7657357

O=C(CC/C=C/c1ccccc1)OOC(=O)CC/C=C/c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAM P19021 1/20 0.53
HDAC3 O15379 2/20 0.49
HDAC4 P56524 2/20 0.49
HDAC1 Q13547 2/20 0.49
HDAC7 Q8WUI4 2/20 0.49
HDAC2 Q92769 2/20 0.49
HDAC10 Q969S8 2/20 0.49
HDAC11 Q96DB2 2/20 0.49
HDAC8 Q9BY41 2/20 0.49
HDAC6 Q9UBN7 2/20 0.49
HDAC9 Q9UKV0 2/20 0.49
HDAC5 Q9UQL6 2/20 0.49
AKT1 P31749 1/20 0.45
MAOB P27338 1/20 0.45
ALDH1A1 P00352 2/20 0.44
IDO1 P14902 2/20 0.44
LMNA P02545 2/20 0.44
TNKS O95271 1/20 0.44
HCAR2 Q8TDS4 1/20 0.44
TNKS2 Q9H2K2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657362 1.00 PAM (0.53) PAMHDAC3HDAC4HDAC1HDAC7
SCHEMBL7571411 0.86 AKT1 (0.62) PAMHDAC3HDAC4HDAC1HDAC7
SCHEMBL19452350 0.86 AKT1 (0.62) PAMHDAC3HDAC4HDAC1HDAC7
SCHEMBL9419457 0.84 MEN1 (0.51) PAMHDAC3HDAC4HDAC1HDAC7
SCHEMBL827395 0.84 EGFR (0.52) PAMHDAC3HDAC4HDAC1HDAC7
SCHEMBL9419458 0.84 MEN1 (0.51) PAMHDAC3HDAC4HDAC1HDAC7
SCHEMBL827396 0.84 EGFR (0.52) PAMHDAC3HDAC4HDAC1HDAC7
SCHEMBL13631648 0.84 MEN1 (0.51) PAMHDAC3HDAC4HDAC1HDAC7
SCHEMBL3154424 0.83 PAM (0.47) PAMHDAC3HDAC4HDAC1HDAC7
SCHEMBL28044574 0.83 PAM (0.47) PAMHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11865374-B2 Functionalized polymers EVONIK OPERATIONS GMBH (DE) 2024-01-09 US claimed
US-20230312791-A1 FUNCTIONALIZED POLYMERS EVONIK OPERATIONS GMBH (DE) 2023-10-05 US claimed
EP-4200343-A1 FUNCTIONALIZED POLYMERS Evonik Operations GmbH (DE) 2023-06-28 EP claimed
WO-2022038054-A1 FUNCTIONALIZED POLYMERS EVONIK OPERATIONS GMBH (DE) 2022-02-24 WO claimed
EP-3957659-A1 FUNCTIONALIZED POLYMERS Evonik Operations GmbH (DE) 2022-02-23 EP claimed
EP-3710503-B1 FUNCTIONALIZED POLYMERS EVONIK OPERATIONS GMBH (DE) 2022-01-05 EP claimed
US-20200383896-A1 FUNCTIONALIZED POLYMERS EVONIK OPERATIONS GMBH (DE) 2020-12-10 US claimed
EP-3710503-A1 FUNCTIONALIZED POLYMERS Evonik Degussa GmbH (DE) 2020-09-23 EP claimed
CN-111356710-A Functionalized polymers 赢创运营有限公司 2020-06-30 CN claimed
US-4618647-A TWO POLYMERIZATION CATALYSTS UNION CARBIDE CORP. (US) 1986-10-21 US claimed
US-11865374-B2 Functionalized polymers EVONIK OPERATIONS GMBH (DE) 2024-01-09 US disclosed
US-20230312791-A1 FUNCTIONALIZED POLYMERS EVONIK OPERATIONS GMBH (DE) 2023-10-05 US disclosed
EP-4200343-A1 FUNCTIONALIZED POLYMERS Evonik Operations GmbH (DE) 2023-06-28 EP disclosed
CN-111356710-B Functionalized polymers 赢创运营有限公司 2022-04-26 CN disclosed
WO-2022038054-A1 FUNCTIONALIZED POLYMERS EVONIK OPERATIONS GMBH (DE) 2022-02-24 WO disclosed
WO-1997049736-A2 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed
US-4727110-A TWO-STAGE; POLYMER AS STABILIZER UNION CARBIDE CORPORATION (US) 1988-02-23 US disclosed
US-4618647-A TWO POLYMERIZATION CATALYSTS UNION CARBIDE CORP. (US) 1986-10-21 US disclosed
US-4066524-A IMIDAZOLE POLYMERS AND PREPARATION THEREOF WITH RADIATION AND CHEMICAL INITIATOR HERCULES INCORPORATED (US) 1978-01-03 US disclosed
US-3948740-A Polymerization of water soluble monomers with radiation and chemical initiator HERCULES INCORPORATED (US) 1976-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11865374-B2 Functionalized polymers PUF60, PARN, PARG PAM 150/4885HDAC3 1672/4885HDAC4 2353/4885
US-20200383896-A1 FUNCTIONALIZED POLYMERS PUF60, PARN, PARG PAM 150/4885HDAC3 1672/4885HDAC4 2353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.